Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalMari M. Kitahata, Richard D. Moore, Michael J. Silverberg et al.|New England Journal of Medicine|2009Cited by 1.1k
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsMark Sulkowski, Richard D. Moore, David L. Thomas et al.|Hepatology|2002Cited by 521
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and CanadaJohn R. Koethe, Richard D. Moore, Cathy A. Jenkins et al.|AIDS Research and Human Retroviruses|2015Cited by 335
Cumulative Incidence of Cancer Among Persons With HIV in North AmericaMichael J. Silverberg, Robert Dubrow, Bryan Lau et al.|Annals of Internal Medicine|2015Cited by 330
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and CanadaKassem Bourgi, John R. Koethe, Cathy A. Jenkins et al.|Journal of the International AIDS Society|2020Cited by 242